BATON ROUGE, La.--(BUSINESS WIRE)--Representatives from Baton Rouge-based Amedisys, Inc. will be joined by two other national home health care leaders in a webinar to help clarify the confusion among health care providers regarding the upcoming Face-to-Face regulation required by CMS on Wednesday, March 23, from 12:00 – 1:00 p.m. CST. Amedisys (NASDAQ: AMED) is a leading home health care and hospice company, providing care to more than 35,000 patients nationwide every day.
The webinar, titled “Making Sense of the New Medicare Face-to-Face Requirements for Home Health Care and Hospice,” will cover details and answer questions regarding the requirements placed on physicians as well as home care and hospice agency staff in regard to Face-to-Face encounter rules.
The webinar features Dr. Michael Fleming, Amedisys Chief Medical Officer; Dr. Steven Landers, Director of the Center for Home Care and Community Rehabilitation at Cleveland Clinic; Dr. Mary D. Naylor, PhD, RN, FAAN, Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania, School of Nursing; and Jeffrey Jeter, Amedisys Chief Compliance Officer.
“There is no question that home health and hospice play a vital role in allowing patients to receive care at home as an alternative to long hospital or alternative facility stays,” said Dr. Fleming. “Our goal is to help prepare the medical community for the April implementation of the Face-to-Face regulation to ensure that the quality of patient care is not interrupted.”
Those interested in attending the webinar can register at http://antidotecme.com/face2face/. The webinar is supported through an educational grant from Amedisys and is planned and implemented in accordance with the policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Antidote Education Company and Amedisys. The webinar is approved for AMA PRA Category 1 Credit™ and AAFP 1 Prescribed credit. Additionally, this program is approved for 1 contact hour of continuing education by the AANP.
About Amedisys:
Amedisys, Inc. (NASDAQ: AMED) is the nation’s leading health care company focused on bringing home the continuum of care. Each day Amedisys delivers personalized health care services to more than 35,000 individual patients and their families, in the comfort of patients’ homes. Amedisys has two divisions, home health care and hospice. The Company’s state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being one of the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry’s first-ever nationwide Care Transitions program. Amedisys Care Transitions is designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient’s home health plan of care. For more information about the Company, please visit: www.amedisys.com.